The low levels of CTCF in our cell lines tightly mimic those observed in vivo from a panel of tumor xenografts derived from a distinct set of triple-negative breast cancer patient tumors (SI Appendix, Fig. S1B). This evidence concerns the gene CTCF and triple-negative breast carcinoma.